Janney Montgomery Scott Starts GW Pharma (GWPH) at Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
GW Pharma's (GWPH) Price Target Raised to $152 at Morgan Stanley
June 28, 2016 7:58 AM EDTMorgan Stanley maintained an Overweight rating on GW Pharma (NASDAQ: GWPH) and raised its price target to $152.00 (from $149.00).
For an analyst ratings summary and ratings history on GW Pharma click here. For more ratings news on GW Pharma click here.
Shares of GW Pharma closed at $88.49 yesterday.
... More